Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Clinical benefit of a high-throughput sequencing approach for minimal residual disease in acute lymphoblastic leukemia.

Wright G, Watt E, Inglott S, Brooks T, Bartram J, Adams SP.

Pediatr Blood Cancer. 2019 Apr 29:e27787. doi: 10.1002/pbc.27787. [Epub ahead of print]

PMID:
31034760
2.

High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments.

Bartram J, Goulden N, Wright G, Adams S, Brooks T, Edwards D, Inglott S, Yousafzai Y, Hubank M, Halsey C.

Haematologica. 2018 Mar;103(3):e110-e114. doi: 10.3324/haematol.2017.174987. Epub 2017 Dec 7. No abstract available.

3.

Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells.

Qasim W, Zhan H, Samarasinghe S, Adams S, Amrolia P, Stafford S, Butler K, Rivat C, Wright G, Somana K, Ghorashian S, Pinner D, Ahsan G, Gilmour K, Lucchini G, Inglott S, Mifsud W, Chiesa R, Peggs KS, Chan L, Farzeneh F, Thrasher AJ, Vora A, Pule M, Veys P.

Sci Transl Med. 2017 Jan 25;9(374). pii: eaaj2013. doi: 10.1126/scitranslmed.aaj2013. Erratum in: Sci Transl Med. 2017 Feb 15;9(377):null.

PMID:
28123068
4.

PAX5 alterations in genetically unclassified childhood Precursor B-cell acute lymphoblastic leukaemia.

Stasevich I, Inglott S, Austin N, Chatters S, Chalker J, Addy D, Dryden C, Ancliff P, Ford A, Williams O, Kempski H.

Br J Haematol. 2015 Oct;171(2):263-272. doi: 10.1111/bjh.13543. Epub 2015 Jun 26.

PMID:
26115422
5.

GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations.

Green CL, Tawana K, Hills RK, Bödör C, Fitzgibbon J, Inglott S, Ancliff P, Burnett AK, Linch DC, Gale RE.

Br J Haematol. 2013 Jun;161(5):701-5. doi: 10.1111/bjh.12317. Epub 2013 Apr 5.

PMID:
23560626

Supplemental Content

Loading ...
Support Center